🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

TLPH TLPH

Company Profile ↓
$1.35
+237.50% 1Y
Mkt Cap$66.59M
P/E-3.97
P/B3.91
52W High$1.46
52W Low$0.39
Book Value$0.35
EPS (TTM)$-0.34

Company Overview

TLPH (TLPH) is a publicly traded company listed on with a market capitalization of $66.59M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.31.

Recent Developments

  • 5-Year Trend Long-term compounding — revenue CAGR -24.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-24.45%
1 Year:-

Stock Price Performance

1 Year:+237.50%
6 Months:+55.17%
3 Months:+50.00%
1 Month:+13.45%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 90% of range
$0.39 $1.46
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • Golden Cross10d ago
  • RSI (14)58.08 · Neutral
Price Performance
1M+13.45%
3M+50.00%
6M+55.17%
1Y+237.50%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Revenue declined at -24.4% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-3.97
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$0.35
Price to Book
3.91
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-24.45%
Profit 5Y
-
Revenue (YoY)
-
Earnings (YoY)
-

Profitability & Returns

ROCE
-52.04%
ROE
-83.89%
ROA
-48.08%
Profit Margin
-
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$-0.04
EPS (TTM)
$-0.34

Balance Sheet & Liquidity

Debt/Equity
0.31
Quick Ratio
5.18
Current Ratio
5.49
Debt
$5.36M
Total Assets
$30.16M
Current Assets
$21.34M
Working Capital
$17.09M

Ownership

Promoter Holding
21.42%
Chg in Prom Hold
-
FII / Inst Holding
34.79%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$28.00K
EBITDA
$-14.36M
Free Cash Flow
$-11.36M
Operating Cash Flow
$-11.36M
Shares Outstanding
49.33M
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 1.92M15.43M1.73M3.02M4.53M3.37M6.43M3.11M2.66M1.49M740.00K343.00K818.00K377.00K613.00K265.00K941.00K608.00K475.00K----------------27.00K01.00K00
Cost of Revenue ----------------------------------------
Gross Profit ----------------------------------------
Operating Expenses -----------------------------------2.94M3.69M3.42M3.45M3.95M
Operating Income -8.12M7.11M--8.52M-8.32M-7.97M--12.07M-9.94M-8.86M--8.27M-7.15M-9.33M--12.32M-13.36M-13.53M--15.85M-6.83M-9.04M-9.14M-10.02M-8.63M-4.94M-13.57M-6.63M-5.33M----4.27M-3.75M--2.92M-3.69M-3.42M-3.45M-3.95M
EBITDA ------------------------------------2.92M-3.49M-4.44M-3.77M-3.95M
Interest Expense ----------------------------------00000-
Pretax Income ------------------------------------2.67M-3.49M-4.44M-3.77M-2.56M
Tax Provision ----------------------------------------
Net Income -8.90M5.07M-10.55M-10.98M-11.09M-11.40M-9.68M-15.55M-13.06M-13.01M-9.88M-11.59M-10.54M-12.46M-12.56M-13.67M-12.41M-12.73M-14.42M-15.93M-6.61M-8.93M-8.96M-9.85M-8.38M-8.67M70.66M-6.75M-8.15M-4.37M-1.36M-3.95M-3.83M-3.35M--2.59M-3.49M-4.44M-3.77M-2.56M
Diluted EPS -0.200.11-0.24-0.25-0.24-0.25-0.21-0.34-0.29-0.28-0.20-------------0.08-1.40-8.58-0.94--0.40-0.08-0.16----0.10-0.10-0.11-0.06-0.04
R&D Expense 7.31M5.39M-4.17M6.28M4.62M-6.92M4.90M3.91M-3.51M3.28M3.64M-1.38M1.16M1.06M-1.41M813.00K956.00K969.00K724.00K1.42M836.00K1.09M799.00K1.05M1.55M1.18M1.43M1.91M2.05M-1.17M1.50M1.80M-1.65M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -----1.07M2.39M29.50M5.22M19.26M17.36M8.00M2.15M2.29M5.42M-0651.00K028.00K
Cost of Revenue ---------------3.75M2.59M---
Gross Profit ----------------935.00K-820.00K---
Operating Expenses ----------------20.35M17.54M15.25M13.51M
Operating Income --------6.67M-37.65M-19.95M-31.96M-38.68M-35.73M-54.20M-40.96M--20.35M-16.89M-15.25M-13.48M
EBITDA ----------------61.90M-9.84M-12.61M-14.36M
Interest Expense ----------------1.12M134.00K394.00K0
Pretax Income ----------------59.14M-10.29M-13.00M-14.36M
Tax Provision ---------------5.00K13.00K0--
Net Income -3.77M-9.63M-20.66M-20.12M-14.34M-20.10M-33.36M-23.43M-33.35M-24.40M-43.16M-51.51M-47.15M-53.24M-40.38M-47.76M-18.40M-13.00M-14.29M
Diluted EPS -------1.51-0.59-0.91-0.60-0.95-1.10----5.72-1.29-0.50-0.34
R&D Expense ---15.50M8.19M13.62M24.91M26.29M24.52M22.49M21.40M19.41M13.14M4.66M4.02M4.09M3.34M5.55M6.72M6.03M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -----6.83M40.84M64.52M110.03M86.42M127.78M99.99M75.55M120.53M91.36M66.30M-47.49M20.39M18.24M29.72M
Current Assets -----------------24.57M11.58M9.42M20.90M
Cash & Equivalents ---6.07M7.15M3.06M7.79M47.93M88.40M60.04M107.92M80.31M52.90M87.97M14.68M27.27M-15.28M5.72M8.86M5.89M
Inventory ----------------1.11M1.18M---
Receivables ----------------160.00K309.00K---
Total Liabilities -----16.78M23.37M30.67M36.87M39.76M94.67M105.33M112.06M116.28M132.77M122.05M-25.67M6.29M10.23M12.68M
Current Liabilities -----13.41M7.84M14.33M6.87M13.73M12.78M10.19M13.66M15.93M13.61M17.64M-13.77M4.51M2.65M3.81M
Long Term Debt ------15.28M8.53M14.36M18.02M16.38M18.64M11.37M3.38M20.52M13.14M5.01M----
Total Debt ----------------18.62M5.36M---
Total Equity -40.00K-3.71M-13.19M-33.34M-52.99M-65.89M17.47M33.85M73.16M46.66M33.11M-5.34M-36.51M4.25M-41.42M-55.75M-21.81M14.11M8.00M17.04M
Shares Outstanding -----------------8.24M16.95M17.03M49.33M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -19.42M-12.22M-15.29M-24.58M-487.00K--19.95M-29.39M-29.77M-29.07M-51.18M-38.51M--28.33M-17.49M-12.68M-11.36M
Investing Cash Flow 8.62M4.76M-29.58M14.96M-6.92M-8.20M1.81M-9.97M-10.88M-36.56M34.14M-36.45M-528.00K3.78M-14.35M
Financing Cash Flow 11.88M3.37M49.60M49.77M47.88M-59.63M-26.00K12.33M75.03M14.45M16.96M--507.00K3.47M12.04M22.74M
Capital Expenditure -111.00K-4.00K-2.02M-826.00K-3.29M-5.50M-1.46M-3.72M-2.40M-819.00K-3.47M-1.85M-1.83M-364.00K-100.00K--
Free Cash Flow -19.53M-12.23M-17.31M-25.41M-3.77M--21.41M-33.12M-32.17M-29.89M-54.65M-40.36M--28.70M-17.59M-12.68M-11.36M
Net Change in Cash -------------7.61M-14.55M3.14M-2.97M

Ratios (Annual)

Figures in %.

Metric Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % --------------------
Operating Margin % --------22.6%-721.7%-103.6%-184.1%-483.8%-1,660.9%-2,368.1%-756.3%---2,594.3%--48,157.1%
Net Margin % ------1,875.1%-1,393.6%-79.4%-639.3%-126.7%-248.6%-644.3%-2,192.0%-2,325.9%-745.6%---2,826.0%--51,035.7%
ROE % 101.4%73.0%62.0%38.0%21.8%-115.1%-98.6%-32.0%-71.5%-73.7%808.6%141.1%-1,108.6%128.5%72.4%-218.9%-130.4%-162.5%-83.9%
ROCE % --------6.5%-51.8%-17.4%-35.6%-62.5%-34.2%-69.7%-84.2%--60.4%-106.3%-97.8%-52.0%

Shareholding Pattern

Insiders
21.42%
Institutions
34.79%
Public Float
44.27%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for TLPH

Yahoo Finance Wed, 05 Aug 2026

Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026

Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will host a conferenc…

Yahoo Finance hu, 14 May 2026

Talphera, Inc. Q1 2026 Earnings Call Summary

Moby summary of Talphera, Inc.'s Q1 2026 earnings call

Yahoo Finance hu, 14 May 2026

Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEFRO Study Progress Amid Rising ...

Talphera Inc (TLPH) reports significant advancements in its NEFRO study, while managing increased operating costs and strategic enrollment updates.

Yahoo Finance Wed, 13 May 2026

Talphera Q1 2026 Earnings Call Transcript

Talphera (NASDAQ:TLPH) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to…

Yahoo Finance Wed, 13 May 2026

Talphera (TLPH) Q1 2026 Earnings Transcript

With this continued progress, we believe we are well positioned to complete enrollment in the nephro CRRT study this year. As mentioned, in early March, we announced the attainment of the 50% enrollment milestone in the nephro study.…

Yahoo Finance Wed, 13 May 2026

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced first quarter 2026 financial …

TLPH — Frequently Asked Questions

What is the current share price of TLPH?

As of 2026-08-05 17:25 PDT, TLPH trades at $1.35 on NASDAQ/NYSE. Its 52-week range is $0.39 to $1.46.

What is the market capitalisation of TLPH?

TLPH has a market capitalisation of $66.59M on NASDAQ/NYSE.

What is the P/E ratio of TLPH?

TLPH trades at a trailing price-to-earnings (P/E) ratio of -3.97. Its price-to-book (P/B) ratio is 3.91.

What is the return on equity (ROE) of TLPH?

TLPH has a return on equity (ROE) of -83.89%. Its return on capital employed (ROCE) is -52.04%.

Is TLPH a good stock to buy?

This page provides a data-driven analysis of TLPH, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space